| Original language | English |
|---|---|
| Publication status | Published - 2005 |
Do blood levels explain clinical differences between whole extract of cannabis and pure delta-9-tetrahydrocannabinol in the treatment of multiple sclerosis symptoms?
Mel Priston, L. J. Teare, J Zajicek, D Wright
Research output: Contribution to conference › Conference paper (not formally published)